.Merck trumps profits requirements, increases purchases expectation on tough need for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Earnings Projections as Keytruda Sales Surge BloombergMerck Inventory: Pharma Giant Posts Sturdy End Results, Yet Overview Drops Short Financier's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps profit as well as purchases assumptions among Keytruda strong point, but provides mixed full-year overview MarketWatch.